Please try another search
For the nine months ended 30 September 2018, Fibria Celulose SA revenues increased 85% to R$14.25B. Net income increased 89% to R$1.53B. Revenues reflect Export segment increase of 87% to R$12.95B, Brazil segment increase of 74% to R$1.22B. Net income benefited from FV Adjustments on Biological Assets decrease from R$223.2M (expense) to R$89.7M (income), Equity in results of joint-venture decrease from R$91K (expense) to R$698K (income).
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 5836.09 | 4722.49 | 3693.17 | 4046.64 |
Gross Profit | 2906.83 | 2106.69 | 1488.02 | 1509.86 |
Operating Income | 2514.5 | 1819.5 | 1162.96 | 1120.31 |
Net Income | 1127.12 | -212.3 | 613.24 | 278.31 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 42698.58 | 40869.07 | 38133.15 | 38693.33 |
Total Liabilities | 26561.29 | 25863.63 | 22932.68 | 24116.17 |
Total Equity | 16137.3 | 15005.43 | 15200.47 | 14577.16 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 5041.66 | 2794.55 | 459.27 | 4105.76 |
Cash From Investing Activities | -4011.15 | -3405.42 | -1130.49 | -5085.72 |
Cash From Financing Activities | -556.85 | -454.33 | -513.82 | 2386.78 |
Net Change in Cash | 894.11 | -768.78 | -1199.27 | 1391.64 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review